跳至主要内容
临床试验/NCT03292003
NCT03292003已完成不适用

Safety and Performance of Journey II BCS Total Knee System. A Retrospective, Multicenter Study

Smith & Nephew, Inc.12 个研究点 分布在 3 个国家目标入组 1,694 人开始时间: 2016年12月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,694
试验地点
12
主要终点
Revision Rate of Total Knee System

研究概览

简要总结

The objective of this study is to estimate the safety and performance of Journey II BCS TKS.

详细描述

The objective of this study is to estimate the safety and performance of Journey II BCS TKS. Specifically, the study will establish revision rate, treatment- and device-related complications, and clinical outcomes in a large sample of subjects who received the study device. Subjects are screened consecutively, beginning at the earliest date of implantation at each investigative site. Further, reasons for revision will be collected and analyzed. An analysis will be performed to identify characteristics (patient, surgeon and surgical) associated with an increased risk for revision. Finally, clinical, functional and quality of life outcomes will be analyzed to the extent data is available, given the retrospective study design.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Subject received primary uni- or bi-lateral total knee arthroplasty with the Journey II BCS Total Knee System for approved indication
  • The TKA occurred at least 12 weeks prior to enrollment
  • Subject records contain Patient Reported Outcome data obtained ≤3 months prior to as well as ≥6 months post-enrollment.

排除标准

  • Subject received the JOURNEY II BCS Total Knee System on the affected knee as a revision for a previously failed total or unicondylar knee arthroplasty

结局指标

主要结局

Revision Rate of Total Knee System

时间窗: implantation through study completion, approximately 3 years

Number of revisions

次要结局

  • Adverse Events(implantation through study completion, approximately 3 years)
  • Clinical outcomes(implantation through study completion, approximately 3 years)
  • Patient reported outcomes(implantation through study completion, approximately 3 years)
  • Health care utilization: Hospitalization(implantation through study completion, approximately 3 years)
  • Health care utilization: Rehabilitation(implantation through study completion, approximately 3 years)
  • Return to Work(implantation through study completion, approximately 3 years)
  • Technical Difficulties Encountered During Device Implantation(implantation through study completion, approximately 3 years)
  • Health care utilization: Outpatient visits(implantation through study completion, approximately 3 years)
  • Health Care Utilization: Re-operations(implantation through study completion, approximately 3 years)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验

Journey II Bi-Cruciate Stabilized (BCS) Total Knee... | 临床试验